www.fdanews.com/articles/98353-sun-pharma-gets-u-s-180-day-exclusivity
Sun Pharma Gets U.S. 180-Day Exclusivity
September 12, 2007
Sun Pharma has become the third Indian pharmaceutical company after Dr. Reddy’s and Ranbaxy to gain 180-day exclusive marketing rights to launch a generic drug in the U.S. market, following the U.S. approval for launching a heartburn and anti-ulcer drug.
Business Standard